OBJECTIVES
To assess the self-reported current dyspnoea and perioperative changes of dyspnoea in long term survivors after minimally invasive segmentectomy or lobectomy for early-stage lung cancer.
METHODS
Cross-sectional telephonic survey of patients alive and disease-free as of March 2023, with pathologic stage IA1-2, non-small cell lung cancer, assessed 1 to 5 years after minimally invasive segmentectomy or lobectomy (performed from January 2018 to January 2022). Current dyspnoea level: Baseline Dyspnoea Index score < 10. Perioperative changes of dyspnoea were assessed using the Transition Dyspnoea Index. A negative Transition Dyspnoea Index focal score indicates perioperative deterioration in dyspnoea.
Mixed effect models were used to examine demographic, medical, and health-related correlates of current dyspnoea and changes of dyspnoea level.
RESULTS
152 of 236 eligible patients consented or were available to respond to the telephonic interview(67% response rate):90 lobectomies and 62 segmentectomies.
The Baseline Dyspnoea Index score was lower (greater dyspnoea) in lobectomy patients (median 7, IQR 6–10) compared to segmentectomy (median 9, IQR 6–11), p = 0.034. 70% of lobectomy patients declared to have a current dyspnoea vs 53% after segmentectomy, p = 0.035.
82% of patients after lobectomy reported a perioperative deterioration in their dyspnoea compared to 57% after segmentectomy, p = 0.002.
Mixed effect logistic regression analysis adjusting for patient related factors and time elapsed from operation showed that segmentectomy was associated with a reduced risk of perioperative dyspnoea deterioration (as opposed to lobectomy) (OR 0.31, p = 0.004).
CONCLUSIONS
Our findings may be valuable to inform the shared decision-making process by complementing objective data on perioperative changes of pulmonary function.